💛 A quick favor, if you've got a second.
We're really happy that you chose to read one of our stories and sincerely hope you'll stick around to read more. We took our paywall down — for now — but that won't last forever, and when the gate goes back up, we'd love for you to already be on the inside.
It's free. So please enter your email here and don't forget to like and follow us on all of your favorite Social Media platforms!
Coco Gauff publicly endorsed the Women’s Tennis Association’s new SRY gene-testing protocol designed to ensure competitive equity in women’s professional tennis. The American champion acknowledged understanding the policy’s scientific rationale while simultaneously voicing disapproval of how the debate has fueled animosity toward transgender individuals.
“I understand the reasoning behind it,” Gauff said. “I do think that this kind of conversation has created a lot of animosity toward the trans community, which I’m not really a big fan of, but I also understand the biological difference and the need to protect that and preserve that.”
Gauff expressed her nuanced position after advancing past Kayla Day in the opening round of the National Open in Toronto. She emphasized support for both fair athletic competition and the transgender community, while warning against weaponizing the eligibility debate for broader political purposes.
“I definitely support the trans community, but I also support the need of creating fairness in sport too,” she stated. “I don’t really know how to answer this question in a way that people aren’t going to spin it.”
Top-ranked Aryna Sabalenka has similarly backed the policy, asserting that biological differences necessitate protective measures. “Biologically, men are way stronger than women, so I feel like it would not really be fair for women to compete against biological men,” Sabalenka said.
The WTA’s updated eligibility requirements mandate a single SRY gene screening via cheek swab, blood test, or saliva sample. Negative results grant immediate tour eligibility, while positive findings require additional medical evaluation before clearance.
Players refusing the test face potential disciplinary sanctions. The WTA implemented the policy after consulting members and reviewing comparable standards adopted across international women’s sports.
More Stories
Mets Reliever Jefry Yan Debuts With Audacious Strikeout Celebration That Captivates Baseball
Cunningham Defends Transgender Athletes Stance Amid Ongoing WNBA Controversy
John Carpenter Blends Horror Vision With Graphic Novel and Original Score in ‘Cathedral’